Dr. Lilia Goudeva

Further involvements

• 21/09/2022

  15:30 – 15:40 6 Min. 4 Min.

  • Abstractvortrag
  • VS-6-4

  Extracorporeal therapy with purified granulocyte concentrates in patients with septic shock – Start of the randomized controlled clinical trial ReActIF-ICE

   13. Neue Blutprodukte – Neue Anwendungen, 9. Hämotherapie
• 22/09/2022

  16:10 – 16:20 6 Min. 4 Min.

  • Abstractvortrag
  • VS-16-3

  The alloCELL program: Patient monitoring, donor selection and GMP-compliant manufacturing of virus-specific T cells from stem cell, family and third-party T-cell donors

   12. Zelltherapie und Gentherapie, 8. Immungenetik: HLA und Transplantationen
• 22/09/2022

  16:45 – 16:50 3 Min. 2 Min.

  • Poster
  • PS-4-5

  Antiviral T-cell frequencies in a healthy population: Reference values for evaluating antiviral immune cell profiles in immunocompromised patients and their application during the SARS-CoV-2 pandemic

   12. Zelltherapie und Gentherapie, 19. COVID-19